✦ LIBER ✦

Double Antiplatelet Therapy After Drug-Eluting Stent Implantation: Risk Associated With Discontinuation Within the First Year

✍ Scribed by Ignacio Ferreira-González; Josep R. Marsal; Aida Ribera; Gaietà Permanyer-Miralda; Bruno García-Del Blanco; Gerard Martí; Purificación Cascant; Mónica Masotti-Centol; Xavier Carrillo; Josepa Mauri; Nuria Batalla; Eduard Larrousse; Eva Martín; Antonio Serra; José Ramón Rumoroso; Rafael Ruiz-Salmerón; Jose M. de la Torre; Angel Cequier; Jose A. Gómez-Hospital; Fernando Alfonso; Victoria Martín-Yuste; Manel Sabatè; David García-Dorado

Book ID: 119271976
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 635 KB
Volume: 60
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2012.04.057

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double jeopardy: balance between bleedin

Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation

✍ Bryan P. Yan; Ronen Gurvitch; Andrew E. Ajani 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 100 KB

TCT-55 Major Adverse Cardiac Events Asso

TCT-55 Major Adverse Cardiac Events Associated With Discontinuation Of Clopidogrel Treatment Within The First Year After Coronary Stent Implantation In Western Denmark

✍ Michael Maeng; Troels Thim; Gro Chisholm; Martin Johansen; Morten Schmidt; Henri 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Comparison of Triple Antiplatelet Therap

Comparison of Triple Antiplatelet Therapy and Dual Antiplatelet Therapy in Patients at High Risk of Restenosis After Drug–Eluting Stent Implantation (from the DECLARE-DIABETES and -LONG Trials)

✍ Seung-Whan Lee; Kook-Jin Chun; Seong-Wook Park; Hyun-Sook Kim; Young-Hak Kim; Su 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 615 KB

TCT-470: Two-Year Dual Antiplatelet Regi

TCT-470: Two-Year Dual Antiplatelet Regimen Abolishes the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation: The TYCOON (Two-Year ClOpidOgrel Need) Study

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 215 KB

AS-42: A Randomized Comparison of Triple

AS-42: A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy in Patients at High-Risk of Restenosis after Drug-Eluting Stent Implantation: 2-year Clinical Outcomes of DECLARE-DIABETES and LONG Trials

✍ Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Duk-Woo Park; Ch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 30 KB

Drug-Eluting Stenting Followed by Cilost

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients)

✍ Lee, Seung Whan (author);Park, Seong Wook (author);Kim, Young Hak (author);Yun, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 483 KB